Guillain-Barré Syndrome Associated with COVID-19 Vaccination
Shih‐Chieh Shao, Chien‐Ho Wang, Kai‐Cheng Chang, Ming‐Jui Hung, Hui‐Yu Chen, Shu‐Chen Liao
Abstract
We conducted a multi-institutional study in Taiwan and a systematic review of the literature for reports of Guillain-Barré syndrome after coronavirus disease vaccination. This condition, mostly the classic form and the acute inflammatory demyelinating polyneuropathy subtype, has been reported in 39 cases and has occurred within 2 weeks of vaccine administration.
Topics & Concepts
Guillain-Barre syndromeCoronavirus disease 2019 (COVID-19)VaccinationVirology2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineBetacoronavirusCoronavirus InfectionsImmunologyBiologyOutbreakPathologyDiseaseInfectious disease (medical specialty)Peripheral Neuropathies and DisordersLong-Term Effects of COVID-19Retinal and Optic Conditions